EPA & DHA Market is segmented By Type (Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA)), By Source (Algae Oil, Krill oil, Fish Oil, Others), By Application (Infant Formulae, Dietary Supplements, Fortified Food and Beverages, Pharmaceuticals, Others), and By Region (North America, Europe, South America, Asia Pacific, Middle East, And Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
EPA & DHA Market Size
The Global EPA & DHA Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 2.9 billion by 2030 and is expected to grow with a CAGR of 6.5% during the forecast period 2024-2031. Personalized nutrition drives EPA & DHA market growth. Companies offer custom Omega-3 supplements based on individual health needs, providing precise EPA and DHA dosages. This EPA & DHA market trend reshapes the market with targeted products.
The EPA & DHA market is a thriving sector within the Omega-3 fatty acids industry. EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid) are long-chain Omega-3 fatty acids known for their significant health benefits, particularly in supporting cardiovascular health and brain function. These essential nutrients are commonly found in fish oil, marine oils, and algal oil, offering a wide range of product options for consumers.
The growing awareness of the health advantages associated with EPA and DHA consumption is a significant market driver. A study published in the American Journal of Clinical Nutrition, that high levels of Omega-3 fatty acids in the blood are linked to a lower risk of cardiovascular disease. As consumers prioritize preventative health measures, demand for EPA and DHA supplements, fish oil, and algal oil products has increased significantly, boosting market growth
EPA & DHA Market Scope
|
Metrics |
Details |
|
CAGR |
6.5% |
|
Size Available for Years |
2022-2031 |
|
Forecast Period |
2024-2031 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Type, Source, Application, and Region |
|
Regions Covered |
North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
|
Fastest Growing Region |
Asia-Pacific |
|
Largest Region |
North America |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For More Insights Request Free Sample
EPA & DHA Market Dynamics
Increasing Awareness of Health Benefits and Rising Demand for Omega-3 Supplements Driving the Market Growth
Growing awareness of the health advantages of EPA and DHA consumption is a primary driving force in the EPA and DHA industry. These Omega-3 fatty acids are well known for their important roles in cardiovascular health and brain function. Demand for fish oil, algal oil, and Omega-3 supplements containing EPA and DHA has increased as consumers become more health-conscious and seek preventive strategies for chronic diseases.
Studies associating Omega-3 consumption with a lower risk of heart disease, increased cognitive function, and overall well-being have fueled market expansion. Manufacturers and suppliers are constantly advertising the health benefits of EPA and DHA, which has raised consumer interest and market growth.
The Versatility of EPA and DHA Drives Market Growth Across Industries
The versatility of EPA and DHA in different industries is driving their market growth. Apart from supplements, EPA and DHA find applications in functional foods, infant formula, pharmaceuticals, and pet nutrition. In the pharmaceutical sector, Omega-3 fatty acids are used to develop prescription medications for managing cardiovascular conditions. The incorporation of EPA and DHA into pet food promotes better pet health, driving the growth of the pet nutrition segment.
Additionally, the potential of algal oil as a sustainable and plant-based source of EPA and DHA has gained attention, appealing to environmentally-conscious consumers and driving innovation in the market. These diverse applications contribute significantly to the rising demand for EPA and DHA products, fostering market expansion across various industries.
Sustainable Sourcing Challenges Pose Constraints on EPA & DHA Market Growth Amid Rising Demand
The limited availability of sustainable and high-quality marine sources is a significant constraint in the EPA & DHA market. Because EPA and DHA are largely found in fish oil and marine oils, overfishing and environmental concerns make obtaining these Omega-3 fatty acids difficult. This may have an influence on the EPA & DHA market size as companies struggle to supply the increased demand for these critical nutrients.
Furthermore, variations in fish populations and climate change-related disruptions might have an impact on the broader supply chain, resulting in price volatility. As a result, the EPA & DHA market share may encounter limits in reaching its full potential, necessitating the industry's exploration of alternative and sustainable sources to ensure long-term growth and meet the needs of consumers.
EPA & DHA Market Segmentation Analysis
The global EPA & DHA market is segmented based on type, source, application, and region.
DHA Dominates with Crucial Brain Health Benefits, EPA Gains Ground with Cardiovascular Support
The EPA & DHA market is segmented by type into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Both EPA and DHA are long-chain Omega-3 fatty acids, but they have different health benefits. Eicosapentaenoic Acid (EPA): EPA is known for its anti-inflammatory properties and its role in supporting cardiovascular health. It is commonly found in fish oil and marine sources. In the EPA & DHA market, EPA usually holds around 35% of the total market share.
DHA is essential for brain health, cognitive function, and fetal development during pregnancy. It is a crucial component of the brain and retina and is found in high concentrations of fish oil and algal sources. In the EPA & DHA market, DHA typically holds a larger share, ranging from 65% of the total market share.
Global EPA & DHA Market Geographical Share
The North America Region Held the Largest Share of EPA & DHA Market.
The North America EPA & DHA market is witnessing robust growth, driven by the increasing awareness of the health benefits of Omega-3 fatty acids, specifically EPA (Eicosapentaenoic Acid) and DHA (Docosahexaenoic Acid). EPA and DHA are essential components of marine oils, with fish oil being a well-known source. These Omega-3 fatty acids play a crucial role in supporting cardiovascular health, brain function, and overall well-being.
The market is characterized by a diverse range of EPA & DHA products, including supplements, fortified foods, and functional beverages, catering to the rising demand for convenient and accessible sources of Omega-3s. As consumer preferences shift towards healthier lifestyles, the EPA & DHA market size continues to expand.
EPA & DHA Market Companies
The major global players in the market include Koninklijke DSM NV, Corbion N.V., BASF SE, The Archer Daniels Midland Company, Croda International Plc, KD Pharma Group, Lonza Group Ltd., Omega Protein Corporation, GC Rieber Oils AS, and Polaris.
COVID-19 Impact On EPA & DHA Market
The COVID-19 pandemic had a multifaceted impact on the EPA and DHA markets. Initially, there was a surge in demand for dietary supplements, including those containing EPA and DHA, as consumers sought to boost their immune systems and overall health during the pandemic. This increased interest in wellness products led to a short-term boost in sales for omega-3 fatty acids.
However, the market also faced challenges due to disruptions in the supply chain and logistics. Restrictions on international trade and lockdown measures affected the production and distribution of EPA and DHA sources, leading to fluctuations in availability and prices. Additionally, the closure of businesses, including fish processing facilities and algae farms, further affected the market's stability.
Key Developments
- On June 17, 2021, Polaris launched high concentration microalgae DHA ingredient, Omegavie DHA 800 Sensory Quality silver 5 algae, an algae oil sourced from microalgae (Schizochytrium sp.) that is rich in vitamins, proteins, pigments, and enzymes. The ingredient offered a plant-based and sustainable origin for polyunsaturated fatty acids (PUFAs).
- On September 13, 2021, KD Pharma Group introduced Alga3, which is a sustainable, vegan omega-3 solution. KD Nutra's superior technology and production flexibility allow for a wide range of omega-3 concentrates. This means the company can customize the EPA and DHA ratio on customer needs, and for any kd-pür fish oil, there is a matching Alga3 plant-based solution.
- On December 08, 2021, Omega-3 concentrates supplier GC Rieber VivoMega announced its plans to expand production facilities and storage tanks to accommodate more ingredients in the upcoming years.
Why Purchase the Report?
- To visualize the global EPA & DHA market segmentation based on type, source, application, and region, as well as understand key commercial assets and players.
- Identify commercial opportunities in the market by analyzing trends and co-development.
- Excel data sheet with numerous data points of EPA & DHA market-level with all segments.
- The PDF report consists of a cogently put-together market analysis after exhaustive qualitative interviews and an in-depth market study.
- Product mapping is available as Excel consists of key products of all the major market players.
The global EPA & DHA market report would provide approximately 61 tables, 62 figures, and 190 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
